Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Allogene Therapeutics (ALLO)
Technical Analysis Report for USA stock ALLO Allogene Therapeutics. Dated: 22 May 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics then click here. or read Experts views on Allogene Therapeutics or Forecast & share price targets of Allogene Therapeutics
Allogene Therapeutics Opened at 1.98 and Closed at: 2.00, which is 2% of previous session's close. It moved within a range of 1.92 and 2.05
The session was a Bullish session with an average volume of 3486615, which is -24.27% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
A Dead cross was found 5 days back on short term averages
Support for tomorrow is 1.96 and resistance for tomorrow is 2.09
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.93, 1.86 resistance for tomorrow's hourly charts is 2.06, 2.12
10 Day SMA for Allogene Therapeutics (ALLO) is 2.08 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Allogene Therapeutics (ALLO) is 2.15 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Allogene Therapeutics (ALLO) is 2.31 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.1 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Allogene Therapeutics is 1.67 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Allogene Therapeutics is at 2.15 and 200 DMA is at 1.67, while 50 DMA and 100 DMA are at 2.31 and 2.1 respectively
Allogene Therapeutics (ALLO) moving average of 20 SMA is at 2.15 and 20 EMA is at 2.14
| Date | Closing Price | 20 SMA | 20 EMA |
| 22 Fri May | 2.00 | 2.15 | 2.14 |
| 21 Thu May | 1.96 | 2.16 | 2.15 |
| 20 Wed May | 1.90 | 2.18 | 2.17 |
| 19 Tue May | 1.88 | 2.2 | 2.2 |
| 18 Mon May | 1.94 | 2.23 | 2.23 |
| 15 Fri May | 2.01 | 2.25 | 2.26 |
Allogene Therapeutics (ALLO) moving average of 50 SMA is at 2.31 and 50 EMA is at 2.21
| Date | Closing Price | 50 SMA | 50 EMA |
| 22 Fri May | 2.00 | 2.31 | 2.21 |
| 21 Thu May | 1.96 | 2.32 | 2.22 |
| 20 Wed May | 1.90 | 2.34 | 2.23 |
| 19 Tue May | 1.88 | 2.35 | 2.24 |
| 18 Mon May | 1.94 | 2.36 | 2.25 |
| 15 Fri May | 2.01 | 2.36 | 2.26 |
Allogene Therapeutics (ALLO) moving average of 100 SMA is at 2.1 and 100 EMA is at 2.07
| Date | Closing Price | 100 SMA | 100 EMA |
| 22 Fri May | 2.00 | 2.1 | 2.07 |
| 21 Thu May | 1.96 | 2.09 | 2.07 |
| 20 Wed May | 1.90 | 2.09 | 2.07 |
| 19 Tue May | 1.88 | 2.08 | 2.07 |
| 18 Mon May | 1.94 | 2.08 | 2.07 |
| 15 Fri May | 2.01 | 2.07 | 2.07 |
Allogene Therapeutics (ALLO) moving average of 200 SMA is at 1.67 and 200 EMA is at 1.91
| Date | Closing Price | 200 SMA | 200 EMA |
| 22 Fri May | 2.00 | 1.67 | 1.91 |
| 21 Thu May | 1.96 | 1.67 | 1.91 |
| 20 Wed May | 1.90 | 1.67 | 1.91 |
| 19 Tue May | 1.88 | 1.66 | 1.91 |
| 18 Mon May | 1.94 | 1.66 | 1.91 |
| 15 Fri May | 2.01 | 1.65 | 1.91 |
Johnson Johnson has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Johnson Johnson, about 11.56% more returns!
Haemonetics Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Haemonetics Corporation, about 18.12% more returns!
Xeris Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Xeris Pharmaceuticals, about 10.32% more returns!
Vistagen Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Vistagen Therapeutics, about 17.01% more returns!
Tiziana Life has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Tiziana Life, about 27.88% more returns!
Soligenix Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Soligenix Inc, about 1.54% more returns!
Pulse Biosciences has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Pulse Biosciences, about 27.28% more returns!
Nucana Plc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 2.63% more returns!
Kalvista Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 47.92% more returns!
Galmed Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Galmed Pharmaceuticals, about 6.99% more returns!
Galectin Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Galectin Therapeutics, about 16.44% more returns!
Fonar Corporation has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Fonar Corporation, about 8.73% more returns!
Entera Bio has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Entera Bio, about 18.41% more returns!
Dare Bioscience has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 16.9% more returns!
Cue Biopharma has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 80.99% more returns!
Citius Pharmaceuticals has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Citius Pharmaceuticals, about 16.37% more returns!
Aptevo Therapeutics has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Aptevo Therapeutics, about 9.49% more returns!
Alector Inc has performed better than Allogene Therapeutics in short term. You could have earned much better returns by investing in Alector Inc, about 1.15% more returns!
Allogene Therapeutics has performed better than Akebia Therapeutics in short term. Holding Allogene Therapeutics could be a better choice for now!
Allogene Therapeutics Technical analysis of indicators
Price action analysis of Allogene Therapeutics (ALLO) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Allogene Therapeutics in short term and the sell signal is strong.
Allogene Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Allogene Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.08 and Allogene Therapeutics ALLO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Allogene Therapeutics ALLO stock. Volume based technical analysis of Allogene Therapeutics ALLO stock is negative.
Allogene Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALLO Allogene Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALLO Experts View which covers a lot of information including buying and selling signals
ALLO future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Allogene Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Allogene Therapeutics (ALLO) Technical (Analysis) Reports Allogene Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


